AI-curated articles from trusted sources.
Cold weather itself won't make you sick, but indoor crowding and dry air do. Here's what actually prevents colds and flu this season, according to medical...
Measles cases have skyrocketed to their highest levels since 1991, with 910 cases already reported in early 2026.
Cold air, indoor crowding, and seasonal immune shifts create ideal conditions for flu, RSV, and COVID-19 to spread.
Antibiotic resistance in common foodborne bacteria like Salmonella and Campylobacter remains a major public health crisis across Europe, with new data...
A major study of 1.1 million people reveals that vaccine hesitancy rooted in distrust is 3 times more likely to lead to persistent refusal than concerns about...
Scientists are racing to develop vaccines against antibiotic-resistant bacteria—a strategy that could prevent millions of infections and reduce reliance on failing antibiotics.
After months of A-strain dominance, influenza B cases are climbing. What this shift means for your winter health strategy.
A major study reveals RSV testing in outpatient clinics is shockingly rare, missing millions of cases and delaying access to new treatments.
As pediatric flu deaths hit a 20-year high, new CDC data reveals a stark vaccination gap among the most vulnerable.
Nearly 1 in 10 doctor visits nationwide are now for flu symptoms—the highest rate since 1997—as 45 states battle surging cases and hospitalizations double.
The AMA and University of Minnesota are creating an independent vaccine review system after concerns about changes to the CDC's advisory process.
New evidence shows vaccines protect heart disease patients as much as diet and exercise—here's what cardiologists want you to know.
The CDC now requires hospitals to report COVID-19, flu, and RSV hospitalizations in real time, giving public health officials unprecedented visibility into which viruses are hitting hardest.
Respiratory syncytial virus (RSV) is growing in 24 states while flu cases are declining in 15, marking a shift in which virus dominates this winter season.
A newly emerged flu variant called subclade K is now responsible for 90% of H3N2 cases, raising concerns about vaccine effectiveness and severe complications in children.
The FDA's refusal to review Moderna's flu vaccine signals a troubling shift in vaccine policy that experts warn could drive innovation overseas and leave the U.S. vulnerable.
